CONTENTS
Issue 68 | March 2018
The number of seamless clinical trials in the oncology space has spiked in recent years
Despite scrutiny on the cost of medicines across the globe, drug pricing policies vary
A recent explosion of fentanyl abuse has had tragic consequences
New research has opened the door to a different approach to tackling HIV
Eli Lilly is investing $1.8bn in a project to develop mRNA cancer vaccines
Self-regulating nanoparticles kill cancerous cells without damaging healthy tissue
Life sciences firms need to adapt how they approach data management
The industry is undergoing dramatic change as new tech brings disruption